NCT00080236: Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation |
|
|
| Completed | 2 | 99 | US, Europe | IDN-6556, Placebo | Conatus Pharmaceuticals Inc., Idun Pharmaceuticals | Liver Transplantation, Hepatitis, Cholestasis, Carcinoma, Hepatocellular | 01/06 | 01/06 | | |
